The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125229701 12522970 1 I 20160622 20160701 20160701 EXP PL-ELI_LILLY_AND_COMPANY-PL201606010042 ELI LILLY AND CO 62.00 YR F Y 80.00000 KG 20160701 CN PL PL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125229701 12522970 1 SS HUMULIN 70/30 INSULIN HUMAN 1 Subcutaneous 26 U, EACH MORNING U 0 26 IU QD
125229701 12522970 2 SS HUMULIN 70/30 INSULIN HUMAN 1 Subcutaneous 14 U, EACH EVENING U 0 14 IU QD
125229701 12522970 3 PS HUMULIN N INSULIN HUMAN 1 Subcutaneous 20 U, QD U 18780 20 IU QD
125229701 12522970 4 SS HUMULIN N INSULIN HUMAN 1 Subcutaneous 8 U, EACH MORNING U 18780 8 IU QD
125229701 12522970 5 SS HUMULIN N INSULIN HUMAN 1 Subcutaneous 10 U, EACH EVENING U 18780 10 IU QD
125229701 12522970 6 SS HUMALOG INSULIN LISPRO 1 Unknown 13 U, EACH MORNING U U 0 13 IU QD
125229701 12522970 7 SS HUMALOG INSULIN LISPRO 1 Unknown 5 U, QD U U 0 5 IU QD
125229701 12522970 8 SS HUMALOG INSULIN LISPRO 1 Unknown 8 U, EACH EVENING U U 0 8 IU QD
125229701 12522970 9 SS HUMALOG INSULIN LISPRO 1 Unknown UNK UNK, PRN U U 0
125229701 12522970 10 SS Abasaglar INSULIN GLARGINE 1 Subcutaneous 16 U, QD U U 0 16 IU QD
125229701 12522970 11 SS HUMULIN NOS INSULIN HUMAN 1 42 U, EACH MORNING U 0 42 IU QD
125229701 12522970 12 SS HUMULIN NOS INSULIN HUMAN 1 Subcutaneous 10 U, QD U 0 10 IU QD
125229701 12522970 13 SS HUMULIN NOS INSULIN HUMAN 1 Subcutaneous 28 U, EACH EVENING U 0 28 IU QD
125229701 12522970 14 C METFORMIN METFORMIN HYDROCHLORIDE 1 3000 MG, QD U 0 3000 MG QD
125229701 12522970 15 C GLIMEPIRIDE. GLIMEPIRIDE 1 6 MG, UNKNOWN U 0 6 MG
125229701 12522970 16 C ACARBOSE. ACARBOSE 1 300 MG, UNK U 0 300 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125229701 12522970 1 Product used for unknown indication
125229701 12522970 3 Product used for unknown indication
125229701 12522970 6 Product used for unknown indication
125229701 12522970 10 Product used for unknown indication
125229701 12522970 11 Product used for unknown indication
125229701 12522970 16 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125229701 12522970 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125229701 12522970 Blood creatine decreased
125229701 12522970 Blood glucose decreased
125229701 12522970 Blood glucose increased
125229701 12522970 Gastroenteritis
125229701 12522970 Glycosylated haemoglobin increased
125229701 12522970 Increased appetite
125229701 12522970 Neuroglycopenia
125229701 12522970 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found